Moderna's Breakthrough: FDA Greenlights Its First mRNA Flu Vaccine, Opening Doors for HIV and Malaria Research

Moderna's newly approved mRNA flu vaccine marks a significant milestone, potentially establishing the company in the seasonal flu market. This advancement also highlights the promise of mRNA technology in tackling rapidly evolving diseases and even cancer.